141 related articles for article (PubMed ID: 2514243)
21. Implications for the assay and biological activity of interleukin-4. Results of a WHO international collaborative study.
Mire-Sluis AR; Das RG; Thorpe R
J Immunol Methods; 1996 Jul; 194(1):13-25. PubMed ID: 8690937
[TBL] [Abstract][Full Text] [Related]
22. Implications for the assay and biological activity of interleukin-8: results of a WHO international collaborative study.
Mire-Sluis AR; Gaines Das R; Thorpe R
J Immunol Methods; 1997 Jan; 200(1-2):1-16. PubMed ID: 9005939
[TBL] [Abstract][Full Text] [Related]
23. Physicochemical methods for predicting the biological potency of recombinant follicle stimulating hormone: an international collaborative study of isoelectric focusing and capillary zone electrophoresis.
Storring PL; Gaines Das RE; Mulders JW; Halder M
Biologicals; 2002 Sep; 30(3):217-34. PubMed ID: 12217346
[TBL] [Abstract][Full Text] [Related]
24. Studies on the relative in-vitro biological potency of the naturally-occurring isoforms of intrapituitary follicle stimulating hormone.
Zambrano E; Barrios-de-Tomasi J; Cárdenas M; Ulloa-Aguirre A
Mol Hum Reprod; 1996 Aug; 2(8):563-71. PubMed ID: 9239668
[TBL] [Abstract][Full Text] [Related]
25. Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone.
Mannaerts B; de Leeuw R; Geelen J; Van Ravestein A; Van Wezenbeek P; Schuurs A; Kloosterboer H
Endocrinology; 1991 Nov; 129(5):2623-30. PubMed ID: 1935792
[TBL] [Abstract][Full Text] [Related]
26. The international reference preparation of calcitonin, human, for bioassay: assessment of material and definition of the international unit.
Gaines Das RE; Zanelli JM
Acta Endocrinol (Copenh); 1980 Jan; 93(1):37-42. PubMed ID: 7355664
[TBL] [Abstract][Full Text] [Related]
27. Establishment of a WHO Reference Reagent for anti-Mullerian hormone.
Ferguson J; Hockley J; Rigsby P; Burns C
Reprod Biol Endocrinol; 2020 Aug; 18(1):86. PubMed ID: 32799874
[TBL] [Abstract][Full Text] [Related]
28. International collaborative study by in vitro bioassays and immunoassays of the First International Standard for Inhibin, Human Recombinant.
Rose MP; Gaines Das RE
Biologicals; 1996 Mar; 24(1):1-18. PubMed ID: 8733597
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism of human pituitary FSH: analysis of immunoreactivity and in vitro bioactivity of different molecular species.
Simoni M; Jockenhövel F; Nieschlag E
J Endocrinol; 1994 May; 141(2):359-67. PubMed ID: 8046307
[TBL] [Abstract][Full Text] [Related]
30. The first international standard for human leptin and the first international standard for mouse leptin: comparison of candidate preparations by in vitro bioassays and immunoassays.
Robinson CJ; Gaines Das R; Woollacott D
J Mol Endocrinol; 2001 Aug; 27(1):69-76. PubMed ID: 11463577
[TBL] [Abstract][Full Text] [Related]
31. Implications for the assay and biological properties of interleukin-3. Results of a WHO international collaborative study.
Mire-Sluis AR; Das RG; Thorpe R
J Immunol Methods; 1996 Jul; 194(1):1-12. PubMed ID: 8690936
[TBL] [Abstract][Full Text] [Related]
32. Plasma clearance in the rat of the LH bioactivity of two human LH standards of differing molecular composition.
Storring PL; Khan SA; Mistry YG; Diczfalusy E
J Endocrinol; 1988 Nov; 119(2):327-4. PubMed ID: 3199063
[TBL] [Abstract][Full Text] [Related]
33. Varying dose-response characteristics of different immunoassays and an in-vitro bioassay for FSH are responsible for changing ratios of biologically active to immunologically active FSH.
Jockenhövel F; Khan SA; Nieschlag E
J Endocrinol; 1990 Dec; 127(3):523-32. PubMed ID: 2126278
[TBL] [Abstract][Full Text] [Related]
34. Calibration of European pharmacopoeia biological reference preparation for diphtheria vaccine (adsorbed) batch 4.
Stickings P; Rigsby P; Buchheit KH; Sesardic D
Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):1-9. PubMed ID: 20144448
[TBL] [Abstract][Full Text] [Related]
35. Definition and measurement of follicle stimulating hormone.
Rose MP; Gaines Das RE; Balen AH
Endocr Rev; 2000 Feb; 21(1):5-22. PubMed ID: 10696567
[TBL] [Abstract][Full Text] [Related]
36. The International Reference Reagent for insulin-like growth factor-I.
Bristow AF; Gooding RP; Das RE
J Endocrinol; 1990 May; 125(2):191-7. PubMed ID: 2373974
[TBL] [Abstract][Full Text] [Related]
37. Multicentre collaborative study to calibrate IGF-II by bioassay and immunoassay: establishment of the First WHO Reference Reagent.
Rafferty B; Rigsby P; Gaines-Das RE
Growth Horm IGF Res; 2001 Feb; 11(1):18-23. PubMed ID: 11437470
[TBL] [Abstract][Full Text] [Related]
38. The international standard for platelet-derived growth factor-BB: comparison of candidate preparations by in vitro bioassays and immunoassays.
Robinson CJ; Stammers R; Gaines-Das R
Growth Factors; 1998; 16(2):153-60. PubMed ID: 9932232
[TBL] [Abstract][Full Text] [Related]
39. The 2nd International Standard for Interleukin-2 (IL-2). Report of a collaborative study.
Wadhwa M; Bird C; Heath AB; Dilger P; Thorpe R;
J Immunol Methods; 2013 Nov; 397(1-2):1-7. PubMed ID: 23948423
[TBL] [Abstract][Full Text] [Related]
40. The First International Standard For Insulin-like Growth Factor-1 (IGF-1) for immunoassay: preparation and calibration in an international collaborative study.
Burns C; Rigsby P; Moore M; Rafferty B
Growth Horm IGF Res; 2009 Oct; 19(5):457-62. PubMed ID: 19303800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
